Genotification of the human papilloma virus in female patients treated in an oncology hospital in Ecuador

Genotification of the human papilloma virus in female patients treated in an oncology hospital in Ecuador

• Raúl Chávez Universidad Laica Eloy Alfaro de Manabí
• Anaxímenes León Universidad del Zulia
• Elisa Rodríguez Universidad Laica Eloy Alfaro de Manabí

Keywords: genotification, human papillomavirus, patient

Abstract

In order to analyze the genotification of human papilloma virus in patients at the Julio Villacreses Colmont oncological hospital in the city of Portovie-jo, Manabí province, Ecuador, a cross-sectional des-criptive observational study was carried out, whose population census consisted of 1088 patients. fe-male aged between 18 and 61 years. The collection instrument was the review of the clinical medical history, for which a file was prepared in which all the variables under study were considered, validated by groups of experts in the area, where it was con-sidered: area of origin of the canton and the Similar-ly, age for HPV genotification was performed using the Cobas 4800 qualitative in vitro test that detects 14 types of RA-HPV (high-risk human papillomavi-rus), such as first-RA-HPV high-risk genotypes (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68), and GET 16 and GET 18. A heterogeneous distribution was evidenced in relation to the viral oncogenic risk, detecting three different genotypes of the virus hu-man papilloma: high risk en bloc of RA-HPV (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 66) (36.31%), high risk GET 16 (6, 52%) and GET 18 (0.37%). It is concluded that the sexually transmitted infection caused by the human papilloma virus (HPV) and its association with a predisposing factor such as age increases the risk of suffering deleterious effects on the health of the population. The need to expand the vaccine program against HPV infections for the epidemiological surveillance of HPV from RA-HPV is suggested (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 66).

References

Andrew W., Hahn M., David H., Spach M. (2018). Human Papillomavirus Infection. Core concepts, Module 1 lesson 10 Disponible en https://www.std. uw.edu/go/pathogen-based/hpv/core-concept/all.

Araiya M., Unger E., Thompson T. (2015). US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J. Natl. Cancer. Inst. 107.

Bedoya C., Medicna L., Espinosa M., Sanchez M., Parrales J., Molina D., Ibarra M., Quimis M., España K., Parraga K.,Cajas N.,Orlando S.,Robalino J.,Chedraui P., Escobar S., Loja R., Ramirez C., Espinoza J.,Sanchez S., Limia C., Aleman Y., Soto Y., Kouri V., Culasso A., Badano I. (2018). Molecular epidemiology and phylogenetic analysis of human papillomavirus infection in women with cervical lesions and cancer from the coastal region of Ecuador. Revista Argentina de Microbiologia. 50(2):136-146.

Bosch F., Broker T., Forman D., Moscicki A., Gillison M., Doorbar J., Stern P., Stanley M., Arbyn M., Poljak M., Cuzick J., Castle P., Schiller J., Markowitz L., Fisher W., Canfell K., Denny L., Franco E., Steben M., Kane M. (2013). Autores de la monografía de la ICO ‘Control integral de las infecciones por VPH y Vacunas contra enfermedades relacionadas Volumen 30, Suplemento 5, 2012. Control integral de infecciones por virus del papiloma humano y enfermedades relacionadas. Vacuna, 31 Suppl 8 (8): 1 – 31.

Bobadilla M., Zorrilla M., Villagra V., Olmedo G., Roscher G., Franco F., Riveros M., Gómez M., Llamosas F. (2015). Detección molecular del virus papiloma humano de alto riesgo oncogénico en muestras cervicales. Laboratorio Central de Salud Pública. Primeros Resultados. Mem. Inst. Investig. Cienc. Salud, 13(1): 17-23.

Bruni L., Diaz M., Castellsague´ X., Ferrer E., Bosch X., Sanjose S. (2010). Comprehensive control of human 515 papillomavirus infections and related diseases. Prevalencia del virus del papiloma humano en 5 continentes: metanálisis de 1 millón de mujeres con hallazgos citológicos normales. Revista de enfermedades infecciosas, 202 (12): 1789-1799.

Bruni L., Barrionuevo Rosas L., Albero G., Serrano B., Mena G., Bosch F. (2017). Comprehensive control of human 515 papillomavirus infections and related diseases. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. The Lancet Global Health, 4 (7): 453-463.

Clifford G., Smith J., Plummer M., Munoz N., Franceschi S. (2003) Tipos de virus del papiloma humano en el cáncer de cuello uterino invasivo en todo el mundo: un metanálisis. Br J Cancer 88(1):63-73.

Cobo F., Concha Á., Ortiz M. (2009). Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study. Open.Virol. J. 3: 60–66.

De Villiers E. (2013). Cross roads in the classification of papillomaviruses. Virology. 2-10.

Dickson E., Vogel R., Geller M., Downs L. (2014). Citología cervical e infección por VPH de tipo múltiple: un estudio de 8182 mujeres de 31 a 65 años. Oncología ginecológica, 133 (3): 405– 408. https://doi.org/10.1016/j.ygyno.2014.03.

Doorbar J., Quint W., Banks T., Bravo I., Stoler M., Broker T., Stanly M., et al (2012). La biología y el ciclo de vida de los virus del papiloma humano Vaccine. 30 (5):55-70.

Dreyer G. (2013). Human papillomavirus type distribution in South African women without cytological abnormalities: a periurban study South. Afr. J. Gynaecol. Oncol, 5 (1): 21-27, DOI: 10.1080/20742835.2013.11441218.

Flores C., Soriano D., Figueroa R., Gonzalo G. (2016). Genotipificación del virus del papiloma humano en mujeres que asisten a un hospital gineco-obstétrico de tercer nivel de la Ciudad de México. Revista chilena de ginecología. 81(5): 381-387.

Flores Medina S., García Romero C., Soriano Becerril D., Figueroa Damián R., Márquez Acosta G. (2016). Genotipificacion del virus del papiloma humnks Lano en mujeres que asisten a un hospital ginecobtetrico de tercer nivel de la ciudad de México. Rev Chil Obstet Ginecol; 81(5): 381

Franco E., Villa L., Sobrinho J., Prado J., Rousseau M., Desy M., (1999). Rohan Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J. Infect. Dis.180 (5):1415- 1423.

García S., Domínguez M., Gayete J., Rojo S., Muñoz J., Santos J., Echevarría C., Blanco M., Ramos C., DeFrutos M., López L,Viñuela L.,Tamames S., Redondo P., Jiménez J., Eiros J., Ortiz R. (2017). Prevalencia de virus del papiloma humano en mujeres españolas de un programa de cribado poblacional. Revista española de quimioterapia. 30(3): 177-182.

Hui-Hui X., Wang K., Feng X., Dong S., Lin A. (2018). Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis. Oncotarget, 9 (20): 15386-1539.

Kjaer S., Van den Brule A., Paull G., Svare E., Sherman M., Thomsen B. (2002). Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. Rev Chil Obstet Ginecol Vol;(67):114-20.

Lazcano Ponce E., Herrero R., Muñoz N., Cruz A., Shah K., Alonso P., (2001). Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 91(3):412-20.

López J., Ili C., Brebi P., García P., Capurro I., Guzmán P, (2010). Detección y tipificación de virus papiloma humano en lesiones preneoplásicas de cuello uterino. Rev Med Chile.138: 343-50.

Organización Mundial de la Salud (OMS) (2017). Papilomavirus humano PVH y cáncer cervico uterino). Disponible en https://www.who.int/immunization/diseases/hpv/es/

Orozco Colín, Carrillo García A., Méndez Tenorio A., Ponce d León S., Mohar A., Maldonado Rodríguez R (2010). Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis.14(12): e1082–e1087.

Peralta Rodríguez R., Romero Morelos P., Villegas Ruíz V., Mendoza Rodríguez M., Taniguchi Ponciano K., González Yebra B., (2012). Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis. Infect Agent Cancer. 7(1): 34.
Ying-Qiao L., Wang Y, Lin Y, Weian H, Wang L , Yeshan R, Rajapaksha J, Wang H 2015) Epidemiology and genotype distribution of high risk human papillomavirus in population of hospital opportunistic screening. Int. J. Clin. Exp. Med. 8(9): 16007–16014.